Concepedia

Tjark Reblin

TR

Statistics

Publications

16

Citations

1.1K

H-Index

14

Active since

1975

Affiliations

University Medical Center Hamburg-Eppendorf(Current)

GlaxoSmithKline (Germany)

Universität Hamburg

Eppendorf (Germany)

GlaxoSmithKline (United States)

Tjark Reblin is an author at University Medical Center Hamburg-Eppendorf specializing in life sciences, medicine, and lipid biochemistry.

Publications per year

1975–2019

16

Publications

16

Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.

Matthias Rath, Axel Niendorf, Tjark Reblin et al. · Arteriosclerosis An Official Journal of the American Heart Association Inc · 1989 · 450 citations · Full text

Life Sciences, Biochemistry, Cardiology +17

Social Media Listening for Routine Post-Marketing Safety Surveillance

Gregory Powell, Harry Seifert, Tjark Reblin et al. · Drug Safety · 2016 · 100 citations

Social Sciences, Communication, Marketing +14

Lipoprotein(a) in the arterial wall

Ulrike Beisiegel, Axel Niendorf, Katrin Wolf et al. · European Heart Journal · 1990 · 89 citations

Life Sciences, Biochemistry, Cardiology +16

Safety and Efficacy of Vardenafil, a Selective Phosphodiesterase 5 Inhibitor, in Patients with Erectile Dysfunction and Arterial Hypertension Treated with Multiple Antihypertensives

H. van Ahlen, Klaus W.J. Wahle, W. Küpper et al. · The Journal of Sexual Medicine · 2005 · 78 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Flexible-Dose Vardenafil in Men with Type 1 Diabetes and Erectile Dysfunction

Dan Ziegler, Frank Merfort, H. van Ahlen et al. · The Journal of Sexual Medicine · 2006 · 69 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

1–5 of 16